Development of bioartificial renal tubule devices with lifespan-extended human renal proximal tubular epithelial cells

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2761-2769

  Sanechika, Noriyuki ^a   Sawada, Kaichiro ^a   Usui, Yukio ^a   Hanai, Kazuya ^a   Kakuta, Takatoshi ^a   Suzuki, Hajime ^a   Kanai, Genta ^a   Fujimura, Satoshi ^a   Yokoyama, Tun Aung ^a   Fukagawa, Masafumi ^a   Terachi, Toshiro ^a   Saito, Akira ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bioartificial renal tubule device; renal proximal tubular epithelial cells; replicative lifespan; RNA interference

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA 2 MICROGLOBULIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE 1; GLUCOSE TRANSPORTER 1; MESSENGER RNA; PENTOSIDINE; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOARTIFICIAL RENAL TUBULE DEVICE; CELL CULTURE EQUIPMENT; CELL DIVISION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE TECHNIQUE; GLUCOSE ABSORPTION; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; PRIORITY JOURNAL; RENAL PROXIMAL TUBULAR EPITHELIAL CELL; RNA INTERFERENCE; SODIUM ABSORPTION; WATER ABSORPTION;

CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EPITHELIAL CELLS; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HEMOFILTRATION; HUMANS; KIDNEY TUBULES, PROXIMAL; KIDNEY, ARTIFICIAL; OLIGONUCLEOTIDES, ANTISENSE; POROSITY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80053184902     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr066     Document Type: Article

References (41)

1. Saito A. Development of bioartificial kidneys. Nephrology 2003; 8: S10-S15 (Pubitemid 38056408)
2. Song JH, Humes HD. Renal cell therapy and beyond. Semin Dial 2009; 22: 603-609
3. Humes HD, Buffington DA, MacKay SM et al. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999; 17: 451-455 (Pubitemid 29217896)
4. Humes HD, Weitzel WF, Bartlett RH et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004; 66: 1578-1588 (Pubitemid 39298393)
5. Tumlin J, Wali R, Williams W et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19: 1034-1040
6. Ozgen N, Terashima M, Aung T et al. Evaluation of long-term transport ability of a bioartificial renal tubule device using LLC-PK1 cells. Nephrol Dial Transplant 2004; 19: 2198-2207 (Pubitemid 39214111)
7. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-636
8. Beauséjour CM, Krtolica A, Galimi F et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22: 4212-4222 (Pubitemid 37021749)
9. Allsopp RC, Vaziri H, Patterson C et al. Telomerase length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118
10. Schwarze SR, Shi Y, Fu VX et al. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 2001; 20: 8184-8192 (Pubitemid 34038207)
11. Shay JW, Pereia-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196: 33-39 (Pubitemid 121006368)
12. Bond JA, Wyllie FS, Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 1994; 9: 1885-1889 (Pubitemid 24194154)
13. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831-834 (Pubitemid 27366737)
14. Vaziri H, Benchimol S. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase. Oncogene 1999; 53: 7676-7680 (Pubitemid 30052694)
15. Bodnar AG, Quellette M, Frolkis M et al. Extension of lifespan by introduction of telomerase into normal human cells. Science 1998; 279: 349-352 (Pubitemid 28063364)
16. Kiyono T, Foster SA, Koop JI et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88 (Pubitemid 28520454)
17. Jarrard DF, Sarkar S, Shi Y et al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 1999; 59: 2957-2964 (Pubitemid 29283138)
18. Dickson MA, Hahn WC, Ino Y et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits the life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000; 20: 1436-1447 (Pubitemid 30069263)
19. Rheinwald JG, Hahn WC, Ramsey MR et al. A two-stage, p16(INK4A)-and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomerase status. Mol Cell Biol 2002; 22: 5157-5172 (Pubitemid 34700705)
20. Ryan MJ, Johnson G, Kirk J et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48-57 (Pubitemid 24045991)
21. Racusen LC, Wilson PD, Hartz PA et al. Renal proximal tubular epithelium from patients with nephropathic cystinosis: immortalized cell lines as in vitro model systems. Kidney Int 1995; 48: 536-543
22. Racusen LC, Monteil C, Sprignoli A et al. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 1997; 129: 318-329 (Pubitemid 27169434)
23. Orosz DE, Woost PG, Kolb RJ et al. Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells. In Vitro Cell Dev Biol Anim 2004; 40: 22-34 (Pubitemid 38756889)
24. Wieser M, Stadler G, Jennings P et al. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 2008; 295: F1365-F1375
25. Kowolik CM, Liang S, Yu Y et al. Cre-mediated reversible immortalization of human renal proximal tubular epithelial cells. Oncogene 2004; 23: 5950-5957 (Pubitemid 39093539)
26. Wagner RW, Matteucci MD, Lewis JG et al. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 1993; 260: 1510-1514
27. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333-335 (Pubitemid 24363432)
28. Elbashir SM, Harborth J, LendeckelWet al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498 (Pubitemid 32494397)
29. Caplen NJ, Parrish S, Imani F et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742-9747 (Pubitemid 32769374)
30. Baer PC, Nockher WA, HaaseWet al. Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note. Kidney Int 1997; 52: 1321-1331
31. Kanai G, Kakuta T, Sawada K et al. Suppression of parathyroid hormone production in vitro and in vivo by RNA interference. Kidney Int 2009; 75: 490-498
32. Yamada K, Nakata M, Horimoto N et al. Measurement of glucose uptake and intercellular calcium concentration in single, living pancreatic b-cells. J Biological Chem 2000; 275: 22278-22283 (Pubitemid 30621811)
33. Asano M, Fujita Y, Ueda Y et al. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product. Nephron 2002; 91: 688-694 (Pubitemid 34914072)
34. Zamecnik PC, Goodchild J, Taguchi Y et al. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci USA 1986; 83: 4143-4146 (Pubitemid 16057007)
35. Furukawa Y, Piwnica-Worms H, Ernst TJ et al. cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science 1990; 250: 805-808 (Pubitemid 120034303)
36. Reed JC, Stein C, Subasinqhe C et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival; comparison of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 1990; 50: 6565-6567
37. Sato Y, Terashima M, Kagiwada N et al. Evaluation of proliferation and functional differentiation of LLC-PK1 cells on porous polymer membranes for the development of a bioartificial renal tubule device. Tissue Eng 2005; 11: 1506-1515 (Pubitemid 41636436)
38. Inagaki M, Yokoyama TA, Sawada K et al. Prevention of LLC-PK1 cell overgrowth in a bioartificial renal tubule device using a MEK inhibitor, U0126. J Biotechnol 2007; 132: 57-64 (Pubitemid 47503393)
39. Saito A, Aung T, Sekiguchi K et al. Present status and perspectives of bioartificial kidneys. J Artificial Organs 2006; 9: 130-135 (Pubitemid 44453863)
40. Saito A. Present status and perspectives on the development of bioartificial kidneys for treatment of acute and chronic renal failure patients. Hemodial Int 2011; in press
41. Ofuna K. In vitro regeneration of kidney from pluripotent stem cells. Exp Cell Res 2010; 316: 2571-2577